CMPS COMPASS Pathways Plc - American
$11.81▲ +6.88%
Healthcare
Other
After hours
$11.79▼ -0.17%
Oct 27, 5:53 PM ET
Volume 2.27M
Avg Volume (10D) 2.47M
Key Metrics & Fundamentals
Market Cap
$1.64B
P/E Ratio
–
Div Yield
0.00%
52W Range
4.88 - 15.87
% vs 50 MA
-9.31%
% vs 200 MA
14.33%
RSI-14
47.8
MACD Histogram
+0.0800
Beta (1Y vs SPY)
1.51
Free Cash Flow
-$40.31M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$45.50M
COGS
–
Operating Exp
$49.79M
Operating Income
-$49.79M
EBIT
-$49.79M
Pretax Income
-$253.46M
Net Income
-$253.79M
EPS (Diluted)
-1.88
Price & Volume History
Loading chart…
Recent News
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
Business Wire · Oct 27, 2026 6:30 AM ET
Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances
MarketBeat · Oct 21, 2026 2:04 PM ET
COMPASS Pathways (CMPS) Stock May Trade At A Premium After Positive Phase 3 Results
Simply Wall St. · Oct 17, 2026 9:09 PM ET
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Business Wire · Oct 14, 2026 6:30 AM ET
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Oct 2, 2026 6:30 AM ET
COMPASS Pathways (CMPS) Could Be 49% Below Fair Value Following Its Phase III Progress
Simply Wall St. · Sep 30, 2026 11:14 PM ET
Compass Pathways Appoints Kelley Boucher as Chief People Officer
Business Wire · Sep 30, 2026 6:30 AM ET
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
MarketBeat · Sep 24, 2026 8:02 PM ET
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
MarketBeat · Sep 24, 2026 6:02 AM ET
Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
MarketBeat · Sep 22, 2026 5:02 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CMPS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.